Clinical Trial Detail

NCT ID NCT01977677
Title Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Stanford University
Indications

medulloblastoma

gliosarcoma

malignant glioma

oligodendroglioma

glioblastoma multiforme

Therapies

Temozolomide

Plerixafor

Age Groups: adult

No variant requirements are available.